Historical record - last NADAC effective date: 9/18/2024
Product Information
VASCEPA 0.5 GM CAPSULE is a brand product labeled by Amarin Pharma Inc., priced at $1.6611 per EA under NDC 52937000340. Its NADAC has been published 359 times since Nov 22, 2017.
FDA first approved this application on Jul 26, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the icosapent ethyl market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500 mg/1
Manufacturer
Amarin Pharma Inc.NDC
52937000340
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/18/2024
Active Ingredients
ICOSAPENT ETHYLApproval Type
New Drug (NDA)
FDA Application
NDA202057FDA Approved
7/26/2012
TE Code
AB
On Market Since
9/16/2016
Price Statistics
The NADAC for VASCEPA 0.5 GM CAPSULE has been published 359 times since Nov 22, 2017, and over the history we have for it it has risen 38.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6611 per EA |
|---|---|
| All-time high | $1.6723 (Apr 10, 2024) |
| All-time low | $1.1976 (Nov 22, 2017) |
| Median price | $1.6117 |
| Average price | $1.5459 |
| Largest weekly change | +9.0% (Jan 3, 2018) |
| Weeks tracked | 359 |
| Tracking since | Nov 22, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-0.4%
5Y
+3.1%
All
+38.7%
Last surveyed Oct 2, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the icosapent ethyl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amarin Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
icosapent ethyl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VASCEPA 0.5 GM CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VASCEPA 0.5 GM CAPSULE, manufactured by Amarin Pharma Inc., is $1.6611 per EA (NDC 52937000340), effective Oct 2, 2024.
How has the price of VASCEPA 0.5 GM CAPSULE changed over time?
Over the history we have for it, the NADAC for VASCEPA 0.5 GM CAPSULE has risen 38.7%. It has been tracked across 359 weekly CMS publications since Nov 22, 2017.
What are the highest and lowest recorded NADAC prices for VASCEPA 0.5 GM CAPSULE?
Since Nov 22, 2017, the NADAC for VASCEPA 0.5 GM CAPSULE has ranged from a low of $1.1976 (Nov 22, 2017) to a high of $1.6723 (Apr 10, 2024), with a median of $1.6117 per EA.
Are there cheaper alternatives to VASCEPA 0.5 GM CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of VASCEPA 0.5 GM CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VASCEPA 0.5 GM CAPSULE?
VASCEPA 0.5 GM CAPSULE (NDC 52937000340) is labeled by Amarin Pharma Inc., and CMS classifies it as a brand product.